WNK2 and cancer: Multiple pathways, including EGFR/PI3K/Akt, EGFR/mitogen-activated protein kinase, tumor necrosis factor-α and pro-metastatic matrix metalloproteinases are also involved in the mechanism by which EETs induce cancer cell proliferation and survival [3, 7, 21].